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and latent tuberculosis infection followed over timA B S T R A C T
Objective/Background: Interferon (IFN)-c release assays (IGRA) are designed for diagnosing
tuberculosis (TB) infection. The new IGRA, QuantiFERON-TB Plus (QFT-Plus), is based on
the enzyme-linked immunosorbent assay detection of IFN-c after stimulation with
Mycobacterium tuberculosis TB1 and TB2 antigens. TB1 elicits a cellular-mediated immune
(CMI) response by CD4 T cells, and TB2 contains peptides recognized by both CD4 and
CD8 T cells. The aim of the study is to characterize the CMI to QFT-Plus peptides in active
TB and latent TB infection (LTBI) at baseline and during or after specific treatment (follow-
up).
Methods: We enrolled 7 individuals with active TB and 11 individuals with LTBI at baseline
and followed them during the treatment, either for active diseases or preventive therapy.
Peripheral blood mononuclear cells were stimulated with QFT-Plus antigens (TB1, TB2,
and mitogen). Cytokine profile (IFN-c, tumor necrosis factor-a, interleukin-2) and pheno-
type (CD45RA, CD27) of CD4 and CD8 T cells were characterized by flow cytometry.
Results: All the individuals responded to mitogen. CD4 T-cell responses to TB1 and TB2
were similar in both individuals with active TB and those with LTBI evaluated over time.
Differently, we found a higher number of TB2-associated CD8 T-cell responders in individ-
uals with active TB than in those with LTBI. For individuals with active TB, there was no
change in the specific response overtime. Differently, in individuals with LTBI, the number
of CD8 responders to QFT-Plus antigens increased during preventive treatment (TB1 = 5/11
[45%], TB2 = 5/11 [45%]) compared with that at the time of enrolment (TB1 = 1/11 [9%],
TB2 = 1/11 [9%]). Moreover, we analyzed the effector memory profile of T cells responding
to QFT-Plus antigens. The largest component of antigen-specific CD4 T cells (65%) had asearch Unit, Istituto Nazionale per le Malattie Infettive ‘‘L. Spallanzani” Via Portuense 292,
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and latent tuberculosis infection followed over timcentral memory (CD45RACD27+) phenotype at enrolment and during follow-up. In
contrast, specific CD8 T cells, which were analyzed only at follow-up because they were
almost absent at baseline, were characterized by a large component with naı¨ve (CD45RA
+CD27+) phenotype (40%) and a minor component with central memory (25%) features.
Conclusion: To our knowledge, this is the first report characterizing CD4 and CD8 T-cell
responses of individuals with active TB and with LTBI, followed overtime, to QFT-Plus
antigens by flow cytometry. The results, although preliminary, may help in identifying
better tools for monitoring therapy, especially in those with LTBI undergoing preventive
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